GlassScriptPhysician profile
Clement C Yeh
NPI 1275744435
$29,249.21
in general payments reported to CMS, 2019-2025
54 companies · $2,618 in 2025
The $2,618 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,850 · 2020: $3,708 · 2021: $4,666 · 2022: $6,584 · 2023: $3,345 · 2024: $3,478 · 2025: $2,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,441.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,570.62 | 2019-2025 | Proclaim, Eterna, Octrode |
| Relievant Medsystems, INC. | $1,545.81 | 2021-2023 | Intracept |
| Spinal Simplicity, LLC | $1,466.17 | 2022-2025 | Ha Minuteman G3-R |
| Vertiflex, INC. | $1,413.48 | 2019 | |
| Si-Bone, INC. | $986.82 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $882.35 | 2019-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $789.31 | 2019-2025 | Intracept |
| Arbor Pharmaceuticals, INC. | $517.02 | 2019-2022 | |
| Medtronic, INC. | $491.76 | 2021-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Protega Pharmaceutials INC | $421.36 | 2025 | Roxybond |
| Abbvie INC. | $373.07 | 2021-2025 | Ubrelvy, Qulipta |
| Teva Pharmaceuticals USA, INC. | $372.17 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $368.60 | 2019-2024 | Ztlido |
| Zyla Life Sciences, INC. | $368.23 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $356.92 | 2019-2025 | Relistor |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clement Yeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.